Life Science

Life Sciences Hub | Zug, Switzerland

11 of November 2025

What Drives Innovation in Life Sciences and the Role of Switzerland

This week, key voices from across the sector gathered at Roche Diagnostics International Ltd., Rotkreuz for the Life Science Hub Zug event hosted by the Swiss-American Chamber of Commerce, with support from Roche and Fusion Consulting. The panel featured Chantal Le Floch (Pfizer), Max Pahlow (Johnson & Johnson Innovative Medicine Switzerland), and Katharina M. Gasser (Roche), moderated by Rahul Sahgal (Swiss-American Chamber of Commerce), and opened by Roberto Busin (Fusion Consulting).​

Spotlight on Innovation

Switzerland remains a leading global hub for life sciences, but sustaining this edge demands continuous adaptation. The discussion highlighted several critical factors:

  • Accelerating access to innovative therapies

  • Embracing digital transformation

  • Prioritizing clinical trial excellence

Panelists emphasized that collaboration, regulatory foresight, and industry-driven change will be essential for Switzerland to safeguard its competitiveness and continue to shape the future of healthcare.

Thanks to Our Community

A big thank you goes to everyone who contributed to this dynamic exchange—your commitment and expertise help reinforce Switzerland’s central role in global life sciences innovation.​